Particle.news
Download on the App Store

American Cancer Society Endorses Self-Collected HPV Swabs for Cervical Cancer Screening

By building on recent FDA clearances, the update targets easier access through shorter self-collection intervals plus explicit rules for when to stop screening.

Overview

  • Self-collected vaginal samples are now an acceptable option for primary HPV screening, though clinician-collected cervical specimens remain preferred.
  • When a self-collected test is HPV-negative, repeat screening is recommended in three years; clinician-collected primary HPV testing continues on a five-year schedule.
  • Average-risk individuals should start screening at age 25 and may exit at 65 after negative primary HPV or co-tests at ages 60 and 65, or after three consecutive negative cytology tests if HPV testing is not available.
  • The FDA has authorized multiple self-administered options, including an at-home kit from Teal Health that uses a mailed vaginal swab with provider oversight.
  • ACS says the changes aim to raise screening uptake and reduce disparities, while USPSTF still begins routine HPV screening at 30 and may incorporate self-collection in future updates according to reporting.